News and information about universal access to health care; the impact of restrictive policies and financial challenges on access to treatment; drug stock-outs; and scaling up services.

Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • The final frontier in the fight against Aids? There is still one region where HIV infection rates are on the rise

    Huge global progress has been made in tackling an epidemic which has claimed over 35 million lives since the 1980s. But there’s one region in the world where infection rates from the human immunodeficiency virus (HIV) – the pathogen that causes Aids – have been quietly rising in recent years. The HIV crisis in eastern Europe and central Asia – which gathered pace in the two decades following the disintegration of the Soviet Union in 1991 – has now reached epidemic proportions.

    16 hours ago | Daily Telegraph
  • When we find a cure, price it like Netflix to ensure access

    An essential lesson from the successful fight against AIDS is that early access to effective treatment can avoid long-term costs. For hepatitis C treatment, Louisiana may have found a solution. The Department of Health is working on a new strategy to expand access—one that involves a licensing deal. The state would agree to pay a drug company for medication for several years in exchange for unlimited access to treatment.

    13 August 2018 | The Hill
  • South Africa strikes deal on new TB drug as WHO revisits guidance

    The World Health Organization could soon start promoting a new tuberculosis drug that is now more affordable after South Africa brokered a deal with a pharmaceutical company to slash the price by half.

    13 August 2018 | Devex
  • Unable to Get Meds, Venezuelans With HIV Turn to Guásimo

    An economic crisis is leading to desperation, DIY treatments and death.

    10 August 2018 | Poz
  • Fast Track Cities Quality of Life Survey

    We invite people living with HIV in 29 cities to complete a 10-minute online survey that will can assist us in better understanding the quality of life issues that impact urban AIDS responses. Your name will remain anonymous, but through your input you will have a positive effect on the quality of life of the global community of people living with HIV. The 29 cities include Amsterdam, Athens, Atlanta, Bamako, Bangkok, Berlin, Brussels, Bucharest, Buenos Aires, Dar es Salaam, Denver, Durban, Geneva, Kingston, Lisbon, Libreville, Madrid, Melbourne, Miami, Montréal, Nairobi, New Orleans, New York City, Oakland, Paris, Rio de Janeiro, Salvador de Bahia, San Francisco, and Santiago. UK Fast Track cities (Brighton and London) can fill it in by checking "other".

    09 August 2018 | IAPAC
  • Price Of HIV Viral Load Test Falls, Raising Hopes In Global AIDS Fight

    The Clinton Health Access Initiative, along with several other development agencies, has brokered an agreement to make routine HIV tests more accessible. They're aiming to make HIV viral load tests available for $12 a piece, slashing the price in some markets by more than 50 percent.

    02 August 2018 | NPR
  • Game over for Gilead’s monopoly on Truvada

    The judge of the Court of Justice of the European Union has just returned his verdict: the patent extension granted to Gilead on Truvada in many European countries is now illegal. AIDES has questioned the Intellectual Property misuses of the company for two years and welcomes this European ruling for three reasons: for healthcare systems users, for the sustainability of public budgets and for access to PrEP all over Europe.

    30 July 2018 | AIDES
  • Terrence Higgins Trust launches Access Fund to support people who can’t afford HIV prevention drug PrEP

    The fund will launch in the autumn and is intended to support up to 1,000 people in England and Northern Ireland.

    26 July 2018 | Terrence Higgins Trust
  • UK HIV drugs bill may reduce following court ruling - implications for PrEP

    A ruling today from the European Court of Justice (ECJ) suggests that Gilead’s patent for Truvada (the drug used to treat many people living with HIV, and the drug used for PrEP) may be under threat.

    25 July 2018 | National AIDS Trust
  • Hologic's Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

    Hologic, Inc. announced today the launch of the new Hologic Global Access Initiative, in partnership with the Clinton Health Access Initiative (CHAI) and MedAccess (backed by the U.K. government), to increase affordable access to molecular testing for HIV, hepatitis B and C (HBV and HCV) and human papillomavirus (HPV) in nearly 50 nations around the world. These countries, primarily across Africa and Southeast Asia, make up 90 percent of the HIV disease burden globally.

    25 July 2018 | Hologic press release
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.